Singapore markets closed

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7650+0.0650 (+2.41%)
As of 11:01AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 352.64M
Enterprise value 382.68M
Trailing P/E 66.50
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.81
Price/book (mrq)1.27
Enterprise value/revenue 0.88
Enterprise value/EBITDA 10.56

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3-37.21%
S&P500 52-week change 322.93%
52-week high 34.7050
52-week low 31.9600
50-day moving average 32.7105
200-day moving average 32.9420

Share statistics

Avg vol (3-month) 31.19M
Avg vol (10-day) 31.57M
Shares outstanding 5132.57M
Implied shares outstanding 6132.57M
Float 861.84M
% held by insiders 132.88%
% held by institutions 143.70%
Shares short (15 May 2024) 411.33M
Short ratio (15 May 2024) 47.49
Short % of float (15 May 2024) 431.77%
Short % of shares outstanding (15 May 2024) 48.55%
Shares short (prior month 15 Apr 2024) 48.32M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.34%
Operating margin (ttm)-3.50%

Management effectiveness

Return on assets (ttm)2.01%
Return on equity (ttm)2.15%

Income statement

Revenue (ttm)435.47M
Revenue per share (ttm)3.31
Quarterly revenue growth (yoy)2.20%
Gross profit (ttm)N/A
EBITDA 29.98M
Net income avi to common (ttm)5.81M
Diluted EPS (ttm)0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)88.63M
Total cash per share (mrq)0.67
Total debt (mrq)118.67M
Total debt/equity (mrq)42.68%
Current ratio (mrq)2.74
Book value per share (mrq)2.10

Cash flow statement

Operating cash flow (ttm)25.83M
Levered free cash flow (ttm)13M